Authors' reply to Thomas et al.'s "Comment on 'Early treatment with activated protein C for meningococcal septic shock: case report and literature review' by Hasin et al."

被引:0
作者
Hasin, T
Lebowitz, D
Rot, D
Wiess, Y
Chajek-Shaul, T
Nir-Paz, R
机构
[1] Univ Calif Berkeley, Dept Mol & Cell Biol, Portnoy Lab, Berkeley, CA 94720 USA
[2] Hadassah Hebrew Univ, Ctr Med, Dept Med, Jerusalem, Israel
[3] Hadassah Hebrew Univ, Ctr Med, Dept Anesthesiol & Intens Care, Jerusalem, Israel
[4] Hadassah Hebrew Univ, Ctr Med, Dept Clin Microbiol & Infect Dis, Jerusalem, Israel
关键词
activated protein C; APC; drotrecogin alfa; meningitis; meningococcal sepsis; purpura fulminans;
D O I
10.1007/s00134-005-2849-0
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:1730 / 1730
页数:1
相关论文
共 3 条
[1]   Early treatment with activated protein C for meningococcal septic shock: case report and literature review [J].
Hasin, T ;
Leibowitz, D ;
Rot, D ;
Weiss, Y ;
Chajek-Shaul, T ;
Nir-Paz, R .
INTENSIVE CARE MEDICINE, 2005, 31 (07) :1002-1003
[2]   Activated protein C for the treatment of fulminant meningococcal septicaemia [J].
Thomas, GL ;
Wigmore, T ;
Clark, P .
ANAESTHESIA AND INTENSIVE CARE, 2004, 32 (02) :284-287
[3]   Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies [J].
Vincent, JL ;
Nadel, S ;
Kutsogiannis, DJ ;
Gibney, RTN ;
Yan, SB ;
Wyss, VL ;
Bailey, JE ;
Mitchell, CL ;
Sarwat, S ;
Shinall, SM ;
Janes, JM .
CRITICAL CARE, 2005, 9 (04) :R331-R343